Project Review: Case Study White Paper Technology Overview Healthcare Manufacturing Pharmaceutical Portfolio Government Logistics Financial Business Client Genre Vertical • A company merger greatly increased the GeMM (Genetically Engineered Modified Mice) program’ s internal and external line population. This resulted in a 40% cost overrun, in the first year alone, beyond all post merger financial projections. • Once the various GeMM lines were combined, there was no means to project into the future what the com- bined supply chain would cost and how to control it. • Enable the company to accurately project/predict cost an d FTE requirements for GeMM’ s into the future. • Allow them to optimize the mix of internal and ext

Join for free to read